Large photo

Home | Index of articles


NAFDAC DG declares open 3rd Nigeria Pharma Manufacturers, Lab expo

The 3rd Nigeria Pharma Manufacturers and Lab Expo under the theme: "The Nigerian Pharmaceutical Manufacturing Industry and International Competitiveness," was declared open Monday by the Director General of the National Agency for Food, Drugs Administration And Control, NAFDAC, Dr. Paul Orhi at the The Haven event centre in GRA Ikeja, Lagos.

The three-day affair, which runs until 9 September, is being staged for stakeholders in the health sector to exchange information, products, services and ideas.

The expo is a joint venture of the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria, PMGMAN, and GPE Expo Pvt Limited, and this year's event is attracting over 130 exhibitors and at least 2,500 participants.

In the keynote address to open the expo, the chairman of PMGMAN, Mr. Okey Akpa highlighted the achievements recorded by the Nigerian pharmaceutical companies, which he said included the manufacturing of drugs for neglected tropical diseases.

"The Nigerian pharmaceutical industry has paid adequate attention to the manufacturing of drugs for diseases prevailing in Africa, which international companies are not interested in, such as anti-malaria, sickle cell disease medicines,” adding that over $50m has been invested by Nigerian pharmaceutical companies in the industry in the last five years.

According to him, " Nigeria is currently the biggest pharmaceutical manufacturing country in West Africa. It accounts for more than 65 per cent of the local manufacture of medicines relevant to the people and diseases of our nation and region. They are anti-malaria medicines, anti-retroviral medicines for HIV/AIDS, herbal medicines and medicines for sickle cell diseases and many others.

"Manufacturers processing WHO pre-qualification have invested over 50 million dollars in the last five years."

He however said the newly introduced Common External Tariffs (CET) in West Africa cast a shadow on the industry in Nigeria.

"ECOWAS External Tariffs (CET) is the single factor threatening the industry today. Before its introduction finished pharmaceutical products under the Import HS codes, 3003 and 3004 attracted up to 20% duty. But CET does not allow this. Rather, it attracts zero percent on finished products into countries.

"It is individual countries that are allowed to use protection tax on products which it has capacity for and that is what we are asking for in the industry,' the PMGMAN chairman, Mr. Okey Akpa explained in his keynote address to open the 3rd Nigeria Pharma Manufacturers and Lab Expo.

Left to Right: DG, NAFDAC "Dr. Paul Orhii , Perm Sec. Lagos State Primary Healthcare Board"Dr. Oguntimehin Olukayode, Chairman PMGMAN and MD/CEO SKG Pharma Limited " Mr. Okey Akpa and PSN President " Pharm. Olumide Akintayo during 2015 Nigeria Pharma Manufacturers Expo in Ikeja Lagos.


Large photo


Don't bother whether your sex is legal or illegal. Just go for it. Because the eternal life of your soul depends on whether your sex is good enough on earth.


Large photo



Labour of love: Meet Japan's real-life 40-year-old virgins

Iran as a member of the World Health Organization, the global health agency, has pledged to eliminate hepatitis B and C as public health challenges by 2030. The Health Ministry is implementing schemes to achieve this goal.

"Unprotected sex and risky sexual behavior among jail inmates and addicts in rehabilitation centers have necessitated making them the main target groups of the programs,” said Dr. Mohammad Mahdi Guya, head of the ministry's Center for Infectious Diseases, at a press conference on the occasion of World Hepatitis Day (July 28).

Fortunately the groups that are at high risk of hepatitis C virus (HCV) and hepatitis B virus (HBV) infection, including prisoners and intravenous drug users, are easily accessible, he said, according to Fararu News website

So far, 35,000 prisoners have been vaccinated against hepatitis B and the ministry plans to extend coverage to all prisoners by the end of the current fiscal year in March 2017.

All prisoners are compulsorily screened for the diseases, and free treatment is provided by the ministry.

A group that is not easily accessible but at great risk of developing HBV, are sex workers. The establishment of specific health centers for this stratum would be an effective measure to keep the disease in check. However there are many constraints in this regard, Guya noted.

"Based on official figures, currently, HBV infection rate is less than 1% among people younger than 28 years of age. The figure is less than 0.5% for individuals below the age of 22."

The prevalence rate of hepatitis B was 5% at one time, but has fallen to less than 2% in all provinces except Sistan-Baluchistan and Golestan where it is a little above 2%.

The decline can be attributed to implementation of the national immunization program that started in 1993 for infants and high-risk age groups.

HBV Prevention Programs

Since then, annually almost all infants (90%) have been given hepatitis B vaccine.

In 2006, the ministry decided to vaccinate, over a four-year period, all those who were born between 1989 and 1992, as they had entered the reproductive years and were at risk of getting the disease if they were sexually active.

In order to reach the goals set by 2030, the Health Ministry should vaccinate all unvaccinated people under the age 40 by the end of 2026. Vaccination of all municipal workers, people working in beauty salons, healthcare workers and infants for HBV is on the agenda.

While official figures say 1.4 million people are infected with the hepatitis B virus, unofficial sources claim that 7% of Iranians carry the virus.

The infected people may or may not show symptoms of the infection since they do not feel or look sick. However, they still can spread the virus to others and are at risk of serious health problems themselves, Guya said.

Infection in Drug Addicts

While HBV can be transmitted via unprotected sex, contact with infected blood, sharing needles, syringes, razors, or toothbrushes with infected person, and mother-to-child during childbirth, HCV is rarely transmitted through unprotected sex.

The main routes of hepatitis C transmission are primarily by needle-sharing with infected people during IV drug use and also mother-to-child in childbirth.

There are between 180,000 to 250,000 people infected with HCV in the country and most of them are injecting drug users. About 96% of infected prisoners are men.

Since 1996, all donated blood is screened for HCV in the country and therefore the risk of acquiring HCV infection from transfused blood has been reduced to almost zero.

At a recent seminar on "Eliminating Hepatitis C by 2030" held at Iran University of Medical Sciences in Tehran, Deputy Health Minister for Research Reza Malekzadeh announced that a domestically produced antiviral biosimilar Interferon (IFN)-based medicine has been introduced under the name 'Sovodak'for treatment of HCV. Given the relatively young age of the HCV infected population in the country, timely intervention is necessary to reverse the rising trend.

HCV infection is a growing global health issue. Those living with chronic HCV infection are at risk of developing advanced liver diseases such as cirrhosis and hepatocellular carcinoma (HCC).

Setting up harm reduction centers (where homeless men and women can visit to get tested for HIV/AIDS, hepatitis B and C, and receive necessary education as well as means of prevention), methadone therapy for de-addiction which lacks the risks of transmitting the virus and drop-in centers (DICs) for street addicts are among other measures taken to reduce hepatitis infection rate.

Global Data

According to the WHO, in 2013, viral hepatitis was a leading cause of death worldwide (1.46 million deaths, a toll higher than that from HIV, tuberculosis or malaria, and on the increase since 1990). More than 90% of this burden is due to the sequelae of infections with HBV and HCV.

So far, HBV infection has affected 400 million people worldwide.

Prevention can reduce the rate of new infections, but the number of those already infected would remain high for a generation. In the absence of additional efforts, 19 million hepatitis-related deaths are anticipated from 2015 to 2030. Treatment now can prevent deaths in the short- and medium term.

Hepatitis B is a contagious liver disease that ranges in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

In fact, Hepatitis B is 50-100 times more infectious than HIV and can be passed through the exchange of body fluids and blood.

Globally, between 130 and 150 million people have chronic hepatitis C infection.

Islamize Europe and get women out of politics. Feminism is the root if terrorism.


Large photo


Feminism in Europe makes second-generation male Muslim immigrants suicide bombers. Up to now it's only explosives. But a poison gas attack isn't far away.


Large photo


Antibiotics lose power to treat sex infections

Growing resistance to antibiotics has complicated the containment of common sexually transmitted infections, the World Health Organization has said.

Releasing new treatment guidelines in Geneva, Switzerland on Tuesday, WHO urged countries to update their national gonorrhoea, syphilis and chlamydia treatment in response to the growing threat of antibiotic resistance.

WHO estimates that at least 131 million people are infected with chlamydia, 78 million with gonorrhoea and 5.6 million with syphilis each year.

According to the WHO, the three common infections, which are generally curable with antibiotics, were facing more limited treatment as they often go undiagnosed and are becoming more difficult to treat with cheaper and more accessible antibiotics.

It said most antibiotics were now failing as a result of misuse and overuse.

The new recommendations are based on the latest evidence on the most effective treatments.

"Because of widespread resistance, older and cheaper antibiotics have lost their effectiveness in treatment," said Ian Askew, director of reproductive health and research, WHO.

"Of the three, gonorrhoea has developed the strongest resistance to antibiotics," he added.

"The new WHO guidelines reinforce the need to treat the infections with the right antibiotic, at the right dose, and the right time to reduce their spread and improve sexual and reproductive health.

"To do that, national health services need to monitor the patterns of antibiotic resistance in these infections within their countries," Askew said.

When left undiagnosed and untreated, the infections can result in serious complications and long-term health problems such as infertility and ectopic pregnancy.

Every rich man in his right mind want patriarchy as a social and political system. Men rule, and can have harems, one way or the other. And because women are natural cowards, the more violent a society, the more women will retreat. All by themselves. So, welcome violent migrants. They will finish off feminism. Just take precautions to protect yourself. A dangerous world is one ruled by men.


Large photo


Contribute to the neomasculine cause by helping to finance its propaganda. Make an anonymous donation to Serge Kreutz to keep up our websites, and ultimately change the world.


Home | Index of articles